Funding
Funding not disclosed
Founders
Product
Problem
Patients seeking medical cannabis in Canada face fragmented access, requiring coordination between clinicians, product suppliers, and regulatory compliance, which creates delays, inconsistent product quality, and difficulty obtaining insurance or tax benefits.
Solution
Aomie offers a unified digital platform that connects certified patients, healthcare practitioners, and licensed cannabis product suppliers. After a clinic appointment, patients register with a few clicks, enabling their providers to deliver personalized treatment guidance and curated product recommendations. The platform features standardized cannabis products with defined cannabinoid and terpene profiles, ensuring therapeutic consistency. Integrated care coordination streamlines documentation for insurance claims and tax‑deduction eligibility, reducing administrative burden for both patients and clinicians. A single dashboard provides real‑time access to treatment plans, product ordering, and compliance verification, supporting a patient‑centred approach to medical cannabis therapy.
Target Audience
Primary users are Canadian patients authorized for medical cannabis, licensed healthcare practitioners who prescribe cannabis therapies, and licensed product suppliers seeking a regulated distribution channel.
Features
- Streamlined patient registration linked directly to clinic appointments
- Clinician portal for delivering personalized treatment plans and ongoing guidance
- Marketplace of vetted, high‑quality cannabis products with standardized cannabinoid and terpene profiles
- Automated generation of documentation required for insurance coverage and tax deductions
- Secure, compliant data handling to meet Canadian age and medical cannabis regulations
- Integrated communication tools for coordination between patients, practitioners, and product partners